Inactive Instrument

Company Alexion Pharmaceuticals, Inc.

Equities

ALXN

US0153511094

Pharmaceuticals

Business Summary

Alexion Pharmaceuticals, Inc is a biopharmaceutical company. The Company is focused on discovering, development and commercialization of medicines. The Company's marketed products include ULTOMIRIS, SOLIRIS (eculizumab), STRENSIQ (asfotase alfa), KANUMA (sebelipase alfa) and ANDEXXA (coagulation Factor Xa - [recombinant] inactivated-zhzo). Its ULTOMIRIS product is a long-acting C5 inhibitor, that works by inhibiting the C5 protein in the terminal complement cascade. Its SOLIRIS product is a humanized monoclonal antibody that blocks terminal activity at the doses prescribed. Its Strensiq product is a targeted enzyme replacement therapy for patients with Hypophosphatasia (HPP). Its Kanuma product is a recombinant form of the human lysosomal acid lipase (LAL) enzyme. Its ANDEXXA product is a reversal agent for patients treated with rivaroxaban or apixaban.

Number of employees: 3,837

Sales per Business

USD in Million2019Weight2020Weight Delta
Biopharmaceutical
100.0 %
4,990 100.0 % 6,069 100.0 % +21.63%

Sales per region

USD in Million2019Weight2020Weight Delta
United States
59.4 %
2,763 55.4 % 3,604 59.4 % +30.46%
Europe
21.9 %
1,206 24.2 % 1,327 21.9 % +10.02%
Asia Pacific
10.9 %
528 10.6 % 664 10.9 % +25.59%
Rest of the World
7.8 %
493 9.9 % 475 7.8 % -3.73%

Managers

Managers TitleAgeSince
Chief Executive Officer 71 -
Director of Finance/CFO - 21-07-31
Chief Tech/Sci/R&D Officer - 20-11-30
Chief Tech/Sci/R&D Officer - 23-05-31
Chief Tech/Sci/R&D Officer - 23-06-30
Compliance Officer - 17-07-31
Chief Tech/Sci/R&D Officer 49 -
General Counsel - -
Human Resources Officer - 13-12-31
Corporate Officer/Principal 57 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 243,075,313 221,078,742 ( 90.95 %) 21,400,000 ( 8.804 %) 90.95 %

Company contact information

Alexion Pharmaceuticals, Inc.

121 Seaport Boulevard

02210, Boston

+(475) 230 2596

http://www.alexion.com
address Alexion Pharmaceuticals, Inc.(ALXN)

Group companies

NameCategory and Sector
Alexion Pharma GmbH
Pharmaceuticals: Major
Pharmaceuticals: Major
Alexion Business Services Pvt Ltd.